ロード中...
Current pharmacological treatments for SARS-COV-2: A narrative review
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis...
保存先:
| 出版年: | Eur J Pharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320862/ https://ncbi.nlm.nih.gov/pubmed/32603692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173328 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|